Zhitong Finance App News, ST Renfu (600079.SH) announced that the company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., recently received a marketing license approval letter for fentanyl citrate injections approved and issued by the German Federal Institute for Drugs and Medical Devices (BfArM). Fentanyl citrate injections are narcotic analgesics. After obtaining marketing approval from the German BfArM, they can be sold in Germany, which will have a positive impact on the company's international business expansion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.